|
|||||
|
|
18F‐RB390: Innovative ligand for imaging the T877A androgen receptor mutant in prostate cancer via positron emission tomography (PET) |
|
| Authors: | Reto Bertolini PhD Christine Goepfert DVM Thomas Andrieu PhD Sara Nichols PhD Martin A. Walter MD Felix J. Frey MD J. Andrew McCammon PhD Brigitte M. Frey PhD |
| Affiliation: | 1. Department of Nephrology & Hypertension and Clinical Pharmacology, University of Berne, Berne, Switzerland;2. Departments of Pharmacology, University of California, San Diego, California;3. Chemistry & Biochemistry, University of California, San Diego, California;4. Department of Nuclear Medicine, University Hospital of Berne, Berne, Switzerland;5. Department of Clinical Research, University of Berne, Berne, Switzerland |
| Abstract: | |
| Keywords: | PET‐Imaging PET/CT scan 18F‐DHT‐derivative androgen receptor T877A‐androgen receptor mutant prostate cancer |